China initiated a year-long foreign investment attraction campaign in Guangzhou
On March 28, the launching ceremony of the "Invest in China Year" series of investment promotion activities was held in Guangzhou, initiating a year-long foreign investment attraction campaign by China MOFCOM for the first time.
Guangdong inks 90.5 bln RMB deals with foreign investors
On the morning of March 29, the special event for presenting Guangdong Province of "Invest in China Year" was held in Guangzhou. 74 major foreign-funded projects were signed, with an investment of 90.5 billion RMB.
China is a R&D powerhouse, welcome more talent to join: Panasonic
"China's opening-up has provided valuable opportunities for foreign companies. The investment environment has also been continuously improving, especially in supporting and encouraging the R&D of foreign companies, which has achieved remarkable results," Tetsuro Homma, Vice President of Panasonic, told GDToday when attending the launching ceremony of the "Invest in China Year" on March 28.
We will build Jiangmen's Quantum into world prebiotics R&D and manufacturing base: Tate & Lyle
"Guangdong enjoys a very sound manufacturing base, good business environment and supporting services. We will increase our investment and develop the Quantum Hi-tech (Guangdong) Biological Co., Ltd. in Jiangmen as our global R&D and manufacturing base for prebiotics," Michelle Liu, Vice President of Corporate Affairs, Asia Pacific, Tate & Lyle, told GDToday while participating in the Special Event of Presenting Guangdong Province of "Invest in China Year" held on March 29.
HSBC to invest an additional 3 billion RMB plus in China by 2025
“In the years 2020 to 2025, we intend to make additional investments totalling 3 billion RMB (in China),” Noel Quinn, the Chief Executive (CEO) of HSBC, announced in an interview with GDToday after the launching ceremony of the “Invest in China Year” on March 28 in Guangzhou.
Sanofi to introduce 25 innovative drugs and indications to Chinese mainland by 2025
Zhu Hailuan, the Vice President of Sanofi China, told GDToday that the company has planned to introduce 25 innovative drugs and indications to the Chinese mainland between 2020 and 2025, when participating in the launching ceremony of the “Invest in China Year” on March 28 in Guangzhou.
China provide opportunities to benefit the business globally: Cummins
“Our customers’ confidence is in China’s internal development, continued growth, adoption of new zero-carbon or low-carbon technologies, and expansion from China overseas. And we will look to do so along with our customers and partners in the country,” said Nathan Stoner, Vice president and Chairman of Cummins China, when chatting with GDToday while participating in the launching ceremony of the “Invest in China Year” in Guangzhou on March 28.
